Loading song details...
Dr Robert Motzer Genitourinary Oncol Service Memorial Sloan Kettering Cancer Center New York USA
No description available.
MP3 Download
Video Download
Related Songs
2:32
Dr Robert Motzer Discusses The Safety And Efficacy Of Tivozanib In Kidney Cancer
2:33
Dr Robert Motzer Reviews The TIVO 1 Study Survival Findings
2:16
Dr Robert Motzer Analyzes Overall Survival In The TIVO 1 Study
6:19
ASCO GU 2013 TIVO 1 Study Shows Tivozanib An Option For Renal Cell Carcinoma Dr Robert Motzer
1:56
Dr Robert Motzer Reviews The Phase III COMPARZ Study
10:40
Dr Robert Motzer Genitourinary Oncol Service Memorial Sloan Kettering Cancer Center New York USA
5:50
Phase II Trial On Nivolumab In MRCC Dr Robert Motzer At ASCO 2014
5:46
TIVO 1 Phase 3 Study In Advanced Kidney Cancer
1:39
Robert J Motzer M D Receives Schonfeld Award From Kidney Cancer Association
1:25
Dr Motzer Discusses Nivolumab For MRCC
3:55
Drugs For Metastatic Kidney Cancer Offer Similar Survival
1:57
Dr Motzer On Nivolumab Versus Everolimus In Renal Call Carcinoma
2:32
Dr Motzer On Sunitinib Versus Pazopanib In Renal Cell Carcinoma
1:08
Dr Motzer On Nivolumab Ipilimumab Activity In RCC
2:24
Robert J Motzer MD Discusses The Side Effect Profiles Of Combinations In CLEAR Trial
2:25
Dr Motzer On A Phase II Trial Of Nivolumab For MRCC
1:11
Dr Motzer On The Milestone Of Immunotherapy In RCC
1:07
Robert J Motzer MD Elaborates On Key Findings From The Phase III CLEAR Trial
1:42
Robert J Motzer MD Considers The Issue Of Drug Resistance In Treating Advanced CcRCC
1:24